NCT04263935Recruiting
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Source: ClinicalTrials.gov · Last updated 23 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 3 Feb 2020
- Start date
- 3 Jan 2019
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Henan Cancer Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT04263935
What you commit to
- Study type: Observational
- Planned participants: 200
- From 3 Jan 2019 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other malignant tumor history or active malignant tumor need be treated
Other
- Researchers determine unsuited to participate in this trial
Who the study is looking for
- Diagnosed as lymphoma (according to WHO 2017 classification criteria)
- Life expectancy no less than 3 months
- Agreeing to sign the written informed consents
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Coordinator of this site? Confirm its status | Zhengzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.